Relative Bioavailability Study of a Pediatric Granule Formulation of Dolutegravir

Clinical trial NCT01382238 · COMPLETED

Trial details

NCT number: NCT01382238
Sponsor: ViiV Healthcare
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Infections, Human Immunodeficiency Virus and Herpesviridae

Start date: 2011-06-01
Primary completion: 2011-08-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.